Beyond Air, Inc. XAIR
Set alert
2.24 USD -0.07 -3.03%
At close · Oct 30
2.20 -0.04 -1.79%
After hours · Oct 30, 7:55 PM ET
2.24 Day range 2.39
2.09 52-week range 43.80
- YTD
- -84.57%
- 1 year
- -94.40%
- Open
- 2.39
- Prev close
- 2.31
- Mkt cap
- 2.21M
- Vol
- 12.52K
- Avg vol
- 223.25K
- EPS
- -64.40
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.24
- High
- 2.39
- Forward P/E
- -0.98
- Beta
- -0.18
- Short ratio
- 1.62
- Inst. own
- 36.40%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 10, 2025
- 50-d avg
- 0.4662
- 200-d avg
- 0.799475
- 1y target
- 2.50
2Y chart
Events in this range
- Nov 11, 2024Earnings: -0.28; estimate -0.3; surprise 6.67%
- Feb 10, 2025Earnings: —; estimate -0.18; surprise —%
- Jul 14, 2025Split: 1 for 20
- Jul 13, 2026Split: 1 for 20
Signals (76)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 19, 2026 | 1 week ago |
| RSI: Oversold | Oct 8, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 18, 2026 | 1 month ago |
| RSI: Oversold | Sep 14, 2026 | 1 month ago |
| RSI: Oversold | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 27, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 24, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 2 months ago |
| RSI: Oversold | Jul 23, 2026 | 3 months ago |
| RSI: Oversold | Jul 14, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jul 1, 2026 | 4 months ago |
| SMA: Bearish | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 10, 2026 | 4 months ago |
| MACD: Buy Signal | May 28, 2026 | 5 months ago |
| MACD: Sell Signal | May 20, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 29, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 15, 2026 | 6 months ago |
| RSI: Oversold | Apr 15, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 1, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 30, 2026 | 7 months ago |
| RSI: Oversold | Mar 26, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 16, 2026 | 7 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 28, 2026 | 9 months ago |
| SMA: Bullish | Jan 13, 2026 | 9 months ago |
| RSI: Overbought | Jan 13, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 2, 2026 | 10 months ago |
| MACD: Sell Signal | Dec 29, 2025 | 10 months ago |
| RSI: Oversold | Dec 15, 2025 | 10 months ago |
| RSI: Oversold | Dec 1, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 26, 2025 | 11 months ago |
| RSI: Oversold | Nov 11, 2025 | 11 months ago |
| SMA: Bearish | Oct 22, 2025 | 1 year ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| SMA: Bearish | Oct 17, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 17, 2025 | 1 year ago |
| SMA: Bullish | Oct 8, 2025 | 1 year ago |
| SMA: Bearish | Oct 7, 2025 | 1 year ago |
| SMA: Bullish | Oct 6, 2025 | 1 year ago |
| SMA: Bearish | Sep 9, 2025 | 1 year ago |
| SMA: Bullish | Sep 8, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 28, 2025 | 1 year ago |
| RSI: Oversold | Aug 20, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 13, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 11, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | Jul 11, 2025 | 1 year ago |
| SMA: Bullish | Jul 8, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 8, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 25, 2025 | 1 year ago |
| SMA: Bearish | Jun 23, 2025 | 1 year ago |
| SMA: Bullish | Jun 20, 2025 | 1 year ago |
| SMA: Bearish | Jun 18, 2025 | 1 year ago |
| SMA: Bullish | Jun 17, 2025 | 1 year ago |
| RSI: Overbought | Jun 17, 2025 | 1 year ago |
| MACD: Buy Signal | May 9, 2025 | 1 year ago |
| MACD: Sell Signal | May 7, 2025 | 1 year ago |
| MACD: Buy Signal | May 1, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 28, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 25, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 24, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 15, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 4, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 17, 2025 | 1 year ago |
| RSI: Oversold | Mar 10, 2025 | 1 year ago |
| RSI: Oversold | Feb 28, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 18, 2025 | 1 year ago |
| SMA: Bearish | Feb 11, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 16, 2025 | 1 year ago |
Key statistics
- Market cap
- 31.86M
- Enterprise value
- 20.89M
- Trailing P/E
- 0.00
- Forward P/E
- -0.98
- PEG ratio
- 0.00
- Price / sales
- 17.87
- Price / book
- 0.81
- EPS (TTM)
- -1.41
- Beta
- -0.18
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 1.78M
- Revenue growth
- 1057.60%
- Free cash flow
- -28.54M
- Total cash
- 21.37M
- Total debt
- 17.70M
- Return on equity
- -219.18%
- Shares outstanding
- 72.19M
- Short % of float
- 2.27%
- 50-day average
- 0.4662
- 200-day average
- 0.799475
Analyst view
Consensus: none
Price target (mean) 2.50 +11.6% upside
Now 2.24
- Target (low)
- 1.00
- Target (mean)
- 2.50
- Target (high)
- 5.00
Ratings (0m) 5 4 buy · 1 hold · 0 sell
- Strong buy3
- Buy1
- Hold1
- Sell0
- Strong sell0
Next earnings
Feb 10, 2025
Expected Feb 10, 2025. Consensus EPS estimate 0.00.
Financials — quick view
XAIR Revenue — quarterly 1.77M
XAIR Net income — quarterly -7.93M
XAIR EPS — quarterly -11.00
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 10, 2025 | Dec 1, 2024 | -0.18 | — | — | — |
| Nov 11, 2024 | Sep 1, 2024 | -0.30 | -0.28 | +0.02 | +6.67% |
| Aug 6, 2024 | Jun 1, 2024 | -0.29 | -0.27 | +0.02 | +6.90% |
| Jun 24, 2024 | Mar 1, 2024 | -0.47 | -0.36 | +0.11 | +23.40% |
| Feb 12, 2024 | Dec 1, 2023 | -0.61 | -0.50 | +0.11 | +18.03% |
| Nov 13, 2023 | Sep 1, 2023 | -0.47 | -0.51 | -0.04 | -8.51% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 2024 | Piper Sandler | main | Overweight | Overweight |
| Jun 25, 2024 | Piper Sandler | main | Overweight | Overweight |
| Jun 25, 2024 | BTIG | down | Buy | Neutral |
| Apr 30, 2024 | Truist Securities | main | Buy | Buy |
| Nov 14, 2023 | Truist Securities | main | Buy | Buy |
| Jul 28, 2023 | Piper Sandler | init | — | Overweight |
About Beyond Air, Inc.
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through two segments, Beyond Air and Beyond Cancer. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. In addition, the company develops ultra-high concentration NO in Phase 1 clinical trial to treat solid tumors. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- beyondair.net
News
- Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended September 30, 2026
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- Beyond Oil Announces First Commercial Adoption in the Industrial Frying Segment
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- Beyond Oil Enters the Romanian Market with Initial Order from New Distributor
- Duchess Restaurants Selects Beyond Oil as Frying Standard Across the Chain
- Beyond Oil Appoints Joe Colligan as Chief Executive Officer of Beyond Oil USA
- Beyond Air Affirms FY2027 Sales Guidance of $16.000M-$18.000M vs $16.715M Est
- Beyond Air Reports Q2 Preliminary Revenue Of ~$2.3M, Reiterates FY26 Revenue Range $16M - $18M
- Beyond Air® Preannounces Preliminary Revenue for the Quarter Ended September 30, 2026
Your note
Sign in to keep a note on XAIR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AVNIEL AMIR | Officer and Director | Sale | Dec 27, 2023 | 0 |
| BENTSUR RON | Director | Purchase | Mar 19, 2023 | 144,736 |
| CAREY ROBERT F. | Director | Purchase | Sep 25, 2024 | 0 |
| FORBES WILLIAM P | Director | Purchase | Mar 30, 2023 | 14,855 |
| GAUL MICHAEL A | Chief Operating Officer | Purchase | Nov 15, 2023 | 88,150 |
| LARSON DOUGLAS QUINTON | Chief Financial Officer | Stock Award(Grant) | Mar 19, 2024 | 27,548 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Lasry, Marc | 6.85% | 4,946,697 | 2.18M | Sep 29, 2024 |
| AIGH Capital Management LLC | 4.99% | 3,602,991 | 1.59M | Sep 29, 2024 |
| Soros Fund Management LLC | 2.05% | 1,476,626 | 651.63K | Sep 29, 2024 |
| Vanguard Group Inc | 1.75% | 1,264,514 | 558.03K | Sep 29, 2024 |
| Bleichroeder LP | 1.02% | 738,313 | 325.82K | Sep 29, 2024 |
| Kingdon Capital Management LLC | 0.79% | 567,526 | 250.45K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.22% | 879,430 | 388.09K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.52% | 374,314 | 165.18K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.27% | 194,649 | 85.90K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.14% | 102,611 | 45.28K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.06% | 46,053 | 20.32K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.06% | 44,497 | 19.64K | Oct 30, 2024 |